Skip to content
Home/Companies/Biotech/Claris Bio

Claris Bio

Biotech·US·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Claris Bio?

Claris Bio is currently owned by Novo Holdings through Novo Holdings Seed Investments (1999 vintage), since 2019.

Hand-verified · updated 2026-08-18

Novo Holdings
Investor
Novo Holdings
Novo Holdings Seed Investments · 1999 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Novo Holdings Seed Investments

Other portfolio companies in the same fund.

cAMPfield
Active
BiotechUS· 2026
Coultreon Biopharma
Active
BiotechUS· 2026
QuantumCell
Active
BiotechDenmark· 2025
Booster Therapeutics
Active
BiotechGermany· 2024
Orbis Medicines
Active
BiotechDenmark· 2024
RheumaLogics
Active
BiotechDenmark· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Claris Bio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Claris Bio?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Claris Bio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue